Biogen Pharmachem Industries Ltd
Incorporated in 1995, Biogen Pharmachem Ltd is in the business of trading in shares and securities in present and future market.
- Market Cap ₹ 73.1 Cr.
- Current Price ₹ 1.12
- High / Low ₹ 1.85 / 0.62
- Stock P/E 73.8
- Book Value ₹ 0.85
- Dividend Yield 0.00 %
- ROCE -0.37 %
- ROE -0.37 %
- Face Value ₹ 1.00
Pros
Cons
- Company has a low return on equity of -1.11% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Finance Industry: Finance & Investments
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.95 | 0.00 | 1.62 | 2.47 | 0.00 | 0.07 | |
0.04 | 0.04 | 0.03 | 0.04 | 0.03 | 0.12 | 6.72 | 0.95 | 0.12 | 3.22 | 2.49 | 0.45 | 0.68 | |
Operating Profit | 0.00 | -0.04 | -0.03 | -0.04 | -0.03 | -0.12 | -6.61 | 0.00 | -0.12 | -1.60 | -0.02 | -0.45 | -0.61 |
OPM % | 0.00% | -6,009.09% | 0.00% | -98.77% | -0.81% | -871.43% | |||||||
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.00 | 0.00 | 0.00 | 0.01 | 0.91 | 1.60 | |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation | 0.10 | 0.10 | 0.10 | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit before tax | -0.10 | -0.14 | -0.13 | -0.14 | -0.03 | -0.12 | -6.56 | 0.00 | -0.12 | -1.60 | -0.01 | 0.46 | 0.99 |
Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||
-0.10 | -0.13 | -0.13 | -0.13 | -0.03 | -0.12 | -6.56 | 0.00 | -0.12 | -1.60 | -0.01 | 0.46 | 0.99 | |
EPS in Rs | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.10 | 0.00 | -0.00 | -0.02 | -0.00 | 0.01 | 0.02 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -104% |
Compounded Profit Growth | |
---|---|
10 Years: | -7% |
5 Years: | 15% |
3 Years: | -31% |
TTM: | 136% |
Stock Price CAGR | |
---|---|
10 Years: | 15% |
5 Years: | 41% |
3 Years: | 72% |
1 Year: | 62% |
Return on Equity | |
---|---|
10 Years: | -2% |
5 Years: | -1% |
3 Years: | -1% |
Last Year: | 0% |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 65.26 | 65.26 | 65.26 | 65.26 | 65.26 | 65.26 | 65.26 | 65.26 | 65.26 | 65.26 | 65.26 | 65.26 | 65.26 |
Reserves | -3.87 | -4.01 | -4.14 | -4.27 | -4.30 | -4.42 | -10.98 | -10.99 | -9.51 | -11.12 | -11.13 | -10.67 | -9.54 |
4.00 | 0.00 | 57.21 | 10.00 | 6.21 | 0.72 | 0.01 | 0.63 | 0.31 | 0.00 | 0.00 | 0.00 | 5.50 | |
1.79 | 3.89 | 4.93 | 2.49 | 1.64 | 1.69 | 1.64 | 2.73 | 0.03 | 0.11 | 0.82 | 0.24 | 0.30 | |
Total Liabilities | 67.18 | 65.14 | 123.26 | 73.48 | 68.81 | 63.25 | 55.93 | 57.63 | 56.09 | 54.25 | 54.95 | 54.83 | 61.52 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 5.75 | 51.87 | 60.86 | 43.78 | 26.69 | 22.39 | 3.52 | 6.25 | 6.45 | 9.49 | 6.95 | 8.85 | 8.80 |
61.43 | 13.27 | 62.40 | 29.70 | 42.12 | 40.86 | 52.41 | 51.38 | 49.64 | 44.76 | 48.00 | 45.98 | 52.72 | |
Total Assets | 67.18 | 65.14 | 123.26 | 73.48 | 68.81 | 63.25 | 55.93 | 57.63 | 56.09 | 54.25 | 54.95 | 54.83 | 61.52 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-9.56 | 0.00 | 0.05 | -7.28 | 4.68 | -0.07 | -13.65 | 0.09 | -1.21 | 3.95 | 1.40 | 1.70 | |
13.77 | 0.00 | -8.99 | 17.08 | 17.08 | 4.30 | 14.32 | -0.72 | 1.54 | -3.64 | -1.32 | -1.66 | |
-4.15 | 0.00 | 10.33 | -11.19 | -21.74 | -4.31 | -0.71 | 0.62 | -0.32 | -0.31 | 0.00 | 0.00 | |
Net Cash Flow | 0.06 | 0.00 | 1.39 | -1.38 | 0.02 | -0.07 | -0.03 | -0.02 | 0.00 | 0.00 | 0.08 | 0.05 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 178,758.75 | 23,326.82 | 3,085.21 | 572.28 | 0.00 | |||||||
Inventory Days | 0.00 | 0.00 | 0.00 | |||||||||
Days Payable | ||||||||||||
Cash Conversion Cycle | 178,758.75 | 23,326.82 | 3,085.21 | 572.28 | 0.00 | |||||||
Working Capital Days | 182,865.00 | 23,194.09 | 2,651.05 | 549.75 | 152.21 | |||||||
ROCE % | -0.16% | -0.22% | -0.14% | -0.15% | -0.04% | -0.19% | -11.32% | 0.00% | -0.22% | -2.90% | -0.02% | -0.37% |
Documents
Announcements
- Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting. 2d
- Submission Of Certificate By PCS Under Regulation 40(9) Of The SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015. 30 Apr
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 27 Apr
- Compliance Certificate Pursuant To Regulation 7(3) Of The SEDI LODR) Reguiations, 2015 For The Period From April 1,2023 To March 31, 2024 24 Apr
- Closure of Trading Window 29 Mar
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
-
Financial Year 2008
from bse
Business Overview:[1]
Company used to deal in shares and securities and traded in commodities including agro based and precious metals and other goods in present and future markets